Whitehawk Therapeutics, Inc. (WHWK)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 9M 18M 27M FY18: 20.2M FY19: 0 FY20: 14M FY21: 14M FY22: 15.2M FY23: 24.4M FY24: 26M FY25: 7.1M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 8M 16M 24M FY21: 14M FY22: 13.9M FY23: 21.5M FY24: 23M FY25: 6.4M FY21 FY22 FY23 FY24 FY25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

-120M -80M -40M 0 40M 80M 120M FY10: -20.5K FY11: -23.6K FY12: -22.4K FY13: -22.8K FY14: -24K FY15: -23K FY16: -16.6M FY17: -21.4M FY18: -11.2M FY19: -24.4M FY20: -2.5M FY21: -111.2M FY22: -62.7M FY23: -71.9M FY24: -67.5M FY25: -114.4M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-120M -80M -40M 0 40M 80M 120M FY08: -33.6K FY09: -20K FY10: -22.4K FY11: -27.2K FY12: -27.4K FY13: -28.7K FY14: -30.8K FY15: -31.4K FY16: -17M FY17: -21.4M FY18: -10.4M FY19: -23.3M FY20: -3.5M FY21: -110.1M FY22: -60.5M FY23: -65.8M FY24: -63.7M FY25: -20.6M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 1.5M 3M 4.5M FY21: 0 FY22: 1.3M FY23: 2.8M FY24: 3M FY25: 760K FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-105M -70M -35M 0 35M 70M 105M FY10: -19.2K FY11: -22.8K FY12: -24.5K FY13: -23.3K FY14: -16K FY15: -21.7K FY16: -24.5K FY17: -18.9M FY18: -5.8M FY19: -23.9M FY20: -12.7M FY21: -22.4M FY22: -49.6M FY23: -59.7M FY24: -59.5M FY25: -97.4M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-105M -70M -35M 0 35M 70M 105M FY16: -137.8K FY17: -18.9M FY18: -5.8M FY19: -24.1M FY20: -12.7M FY21: -22.5M FY22: -50.1M FY23: -63.6M FY24: -61.2M FY25: -98M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 25M 50M 75M FY21: 8.9M FY22: 22.5M FY23: 26.9M FY24: 27M FY25: 61.9M FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-27.00 -18.00 -9.00 0.00 9.00 18.00 27.00 Q4 '10: 0.00 Q1 '11: 0.00 Q2 '11: 0.00 Q3 '11: 0.00 Q4 '11: -0.01 Q1 '12: -0.01 Q2 '12: -0.01 Q3 '12: -0.01 Q4 '12: -0.01 Q1 '13: -0.01 Q2 '13: -0.01 Q3 '13: -0.01 Q4 '13: -0.01 Q1 '14: -0.01 Q2 '14: -0.01 Q3 '14: -0.01 Q4 '14: -0.01 Q1 '15: -0.01 Q2 '15: -0.01 Q3 '15: -0.01 Q4 '15: -0.01 Q1 '16: -7.08 Q2 '16: -13.38 Q3 '16: -20.07 Q4 '16: -24.82 Q1 '17: -18.81 Q2 '17: -12.72 Q3 '17: -6.20 Q4 '17: -1.67 Q1 '18: -0.88 Q2 '18: -0.89 Q3 '18: -0.44 Q4 '18: -0.42 Q1 '19: -0.36 Q2 '19: -0.28 Q3 '19: -0.67 Q4 '19: -0.57 Q1 '20: -0.46 Q2 '20: -0.09 Q3 '21: -12.58 Q4 '21: -12.41 Q1 '22: -10.92 Q2 '22: -11.19 Q3 '22: -2.70 Q4 '22: -2.69 Q1 '23: -2.60 Q2 '23: -2.40 Q3 '23: -2.32 Q4 '23: -2.44 Q1 '24: -2.55 Q2 '24: -2.42 Q3 '24: -2.28 Q4 '24: -2.36 Q1 '25: 0.15 Q2 '25: -0.07 Q3 '25: 0.13 Q4 '25: -0.33 Q1 '26: -2.48 Q2 '26: -1.92 Q2 '11 Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.